Latest Deals

The Truveta Genome Project looks to generate genetic data on tens of millions of consented and de-identified volunteers. Credit: Daily insights / Shutterstock

Illumina and Regeneron have invested in electronic health record data company Truveta to create the world's largest database of genetic information. Illumina and Regeneron, along with 17 health systems such as Northwell Health and Trinity Health, have invested a combined $320m in Truveta preferred equity. Regeneron pledged $119.5m while Illumina is investing $20m in Truveta’s Series C financing round.

Nonprofit healthcare system Sutter Health has announced a seven-year Care Alliance with GE HealthCare, a medical technology and digital solutions provider, with the goal of improving access to diagnostic imaging services across California, US. This long-term partnership will enhance access to vital diagnostic care throughout the state, offering patients advanced technology within their communities.

Owlstone Medical has secured the first closing of its Series E financing round, securing $27m (approximately £22m) to advance the development of its Breath Biopsy platform and the commercialisation of new diagnostic tests and point-of-care devices.Ventura Capital led the round with participation from Horizons Ventures, Aviva Ventures, along with an investment from the Gates Foundation.

Texas medical device firm Alleviant Medical has secured $90m to fund a second pivotal trial of the company’s heart system for patients living with heart failure and reduced ejection fraction (HFrEF). The funding will be used to drive the company’s ALLAY-HFrEF trial, examining the company’s atrial shunt system in approximately 350 randomised patients with reduced left ventricular ejection fraction.